共 50 条
- [41] RETINAL SENSITIVITY AFTER INTRAVITREAL INJECTION OF BEVACIZUMAB FOR THE TREATMENT OF MACULAR EDEMA SECONDARY TO RETINAL VEIN OCCLUSION RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2009, 29 (06): : 757 - 767
- [44] RESPONSE TO AFLIBERCEPT AS SECONDARY THERAPY IN PATIENTS WITH PERSISTENT RETINAL EDEMA DUE TO CENTRAL RETINAL VEIN OCCLUSION INITIALLY TREATED WITH BEVACIZUMAB OR RANIBIZUMAB RETINA-THE JOURNAL OF RETINAL AND VITREOUS DISEASES, 2014, 34 (12): : 2439 - 2443
- [47] Simultaneous intravitreal dexamethasone and aflibercept for refractory macular edema secondary to retinal vein occlusion Graefe's Archive for Clinical and Experimental Ophthalmology, 2020, 258 : 787 - 793
- [48] Outcomes of switching treatment to aflibercept in patients with macular oedema secondary to central retinal vein occlusion refractory to ranibizumab International Ophthalmology, 2018, 38 : 207 - 213
- [50] The comparison of intravitreal triamcinolone and bevacizumab in patients with macular edema secondary to branch retinal vein occlusion CLINICAL OPHTHALMOLOGY, 2014, 8 : 355 - 362